miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling

Author:                

Publisher: Spandidos Publications

ISSN: 1791-2997

Source: Molecular Medicine Reports, Vol.7, Iss.5, 2013-01, pp. : 1579-1584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract